See also this year's filing and all EDGAR filings for this company.
PDF Report 0000748592_2012_Ernexa_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0000748592, Ernexa Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,798,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,081,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,255,000 |
| 3 | remainder_Assets | 2,513,000 |
| 4 | LiabilitiesCurrent | 3,868,000 |
| 5 | LiabilitiesNoncurrent | 323,000 |
| 6 | remainder_Liabilities | 1,106,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,448,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 6,698,000 |
| 11 | remainder_Revenues | 23,870,000 |
| 12 | remainder_NetIncome | 20,000 |
| 13 | remainder_ComprehensiveNetIncome | -223,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,647,000 |
| 1 | Liabilities | 5,297,000 |
| 2 | Expenses | 27,146,000 |
| 3 | Revenues | 23,870,000 |
| 4 | StockholdersEquity | 6,350,000 |
| 5 | NetIncome | -3,256,000 |
| 6 | ComprehensiveNetIncome | -3,367,500 |
| 7 | BaseVar | 34,101,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.24 |
| 9 | EconomicCapitalRatio | 2.48 |
Edgar->Model Mapping
Feature Distribution
